Home > Insider Trading > Filing (0001209191-17-035160)

Filing Details

Accession Number:: 0001209191-17-035160
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-24 20:03:31
Reporting Period:: 2017-05-22

Filing Date:: 2017-05-24
Accepted Time:: 2017-05-24 20:03:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1625101	Pulse Biosciences Inc.	PLSE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055919	W Robert Duggan	611 S. Fort Harrison Ave., Suite 306 Clearwater FL 33756		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-22	27,928	$26.15	3,054,244	No	4	P	Direct
Common Stock	Acquisiton	2017-05-22	6,800	$26.67	3,061,044	No	4	P	Direct
Common Stock	Acquisiton	2017-05-23	18,600	$26.69	3,079,644	No	4	P	Direct
Common Stock	Acquisiton	2017-05-23	28,600	$27.63	3,108,244	No	4	P	Direct
Common Stock	Acquisiton	2017-05-23	2,000	$28.07	3,110,244	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	35,000	Indirect	See footnote

Footnotes

This is the weighted average purchase price of the shares, which ranged from $25.45 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $26.46 to $26.819 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $26.172 to $27.082 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $27.19 to $28.014 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $28.035 to $28.182 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.